In negative controls, rare-cell scWB analyses of pure WBC populations reported only CD45 and GAPDH signal, with no measurable signal from any cancer-specific protein target, thus establishing co-expression of CD45 and GAPDH, and negative cancer marker response as selective for WBCs. The gene discussed is PTPRC; the disease is cancer.